Literature DB >> 2566022

Study of bivalent dengue vaccine in volunteers.

N Bhamarapravati, S Yoksan.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2566022     DOI： 10.1016/s0140-6736(89)92471-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Authors:  Claire Y-H Huang; Siritorn Butrapet; Kiyotaka R Tsuchiya; Natth Bhamarapravati; Duane J Gubler; Richard M Kinney
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 3.  Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.

Authors:  Jorge E Osorio; Claire Y-H Huang; Richard M Kinney; Dan T Stinchcomb
Journal:  Vaccine       Date:  2011-07-21       Impact factor: 3.641

4.  Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study.

Authors:  Jorge E Osorio; Ivan D Velez; Cynthia Thomson; Liliana Lopez; Alejandra Jimenez; Aurelia A Haller; Shawn Silengo; Jaclyn Scott; Karen L Boroughs; Janae L Stovall; Betty E Luy; John Arguello; Mark E Beatty; Joseph Santangelo; Gilad S Gordon; Claire Y-H Huang; Dan T Stinchcomb
Journal:  Lancet Infect Dis       Date:  2014-07-23       Impact factor: 25.071

Review 5.  Dengue and dengue hemorrhagic fever.

Authors:  D J Gubler
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

6.  Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).

Authors:  Claire Y-H Huang; Richard M Kinney; Jill A Livengood; Bethany Bolling; John J Arguello; Betty E Luy; Shawn J Silengo; Karen L Boroughs; Janae L Stovall; Akundi P Kalanidhi; Aaron C Brault; Jorge E Osorio; Dan T Stinchcomb
Journal:  PLoS Negl Trop Dis       Date:  2013-05-30

Review 7.  Utility, limitations, and future of non-human primates for dengue research and vaccine development.

Authors:  Carlos A Sariol; Laura J White
Journal:  Front Immunol       Date:  2014-09-24       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.